Carregant...
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
BACKGROUND: Genomic analyses have suggested that the LPA gene and its associated plasma biomarker, lipoprotein(a) (Lp[a]), represent a causal risk factor for coronary heart disease (CHD). As such, lowering Lp(a) has emerged as a therapeutic strategy. Beyond target identification, human genetics may...
Guardat en:
Publicat a: | J Am Coll Cardiol |
---|---|
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5328146/ https://ncbi.nlm.nih.gov/pubmed/28007139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2016.10.033 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|